Sickle cell anemia affects more than 100,000 people in the United States and millions more around the globe. The genetic disease causes red blood cells to take on a sticky, misshapen form that prevents them from properly carrying oxygen through the body. A new drug, called voxelotor, may change that. In a phase III clinical trial, it boosted levels of hemoglobin—which binds to oxygen inside red blood cells—compared with a placebo, STAT reports. Although outside experts call the increase “modest,” the company behind the drug says it could help reduce the risk of stroke and organ failure in patients, if approved by the Food and Drug Administration.
More Post
Are Diet Pills The Answer?
10 Tips To Minimizing A Plus Size Body Type
Do You Love Yourself
10 Alternate Energy Sources To Live Well With Global Warming.
How To Get Rid Of Raccoons
Can I Go Tanning With Diabetes?
Deadly Relationship Habits
Differences: The Old and New Testament
Satellite Tv for PC
Aloe Vera - The Ancient Healing Plant
The History of Sudoku
What Is A Fossil?
The Fourth Law (of Robotics)
Breastfeeding My Baby, Where Do I Start?
The History of African American
Worship When You’re Down
Who Is Evil?
Mermaid Figurines – Evoking Fantasies Of The Sea
Childbirth and the Athletic Woman
American Churches – Inspiring or Entertaining